- Clinical and diagnostic significance of homocysteine metabolism disorders in pregnancy complications in a woman with severe preeclampsia combined with extragenital pathology (а case report)
Clinical and diagnostic significance of homocysteine metabolism disorders in pregnancy complications in a woman with severe preeclampsia combined with extragenital pathology (а case report)
Ukrainian Journal of Perinatology and Pediatrics. 2024.4(100): 148-156. doi: 10.15574/PP.2024.4(100).148156
Naritnik T. T.1, Kostenko O. Yu.1, Malanchuk O. B.2, Dukmas I. A.2, Govsieiev D. O.1
1Bohomolets National Medical University, Kyiv, Ukraine
2Municipal Non-Profit Enterprise “Perinatal Center of Kyiv”, Ukraine
For citation: Naritnik TT, Kostenko OYu, Malanchuk OB, Dukmas IA, Govsieiev DO. (2024). Clinical and diagnostic significance of homocysteine metabolism disorders in pregnancy complications in a woman with severe preeclampsia combined with extragenital pathology (а case report). Ukrainian Journal of Perinatology and Pediatrics. 4(100): 148-156. doi: 10.15574/PP.2024.4(100).148156.
Article received: Aug 14, 2024. Accepted for publication: Nov 27, 2024.
The relevance of studying homocysteine (Hcy) metabolism disorders lies in their significant impact on maternal and perinatal health, especially in pregnancy complications such as preeclampsia (PE) and diabetes mellitus (DM).
Aim – to evaluate the clinical and diagnostic significance of Hcy metabolism disorders in pregnancy complications in a woman with severe PE combined with DM.
Clinical case. A 35-year-old pregnant woman with chronic arterial hypertension, type II diabetes, and class III obesity. Her obstetric history includes two pregnancies ending in preterm labor (at 30 and 26 weeks), placental dysfunction, intrauterine growth restriction, cesarean section, and perinatal death. Genetic testing revealed homozygous mutations in the SERPINE1 and ITGA2 genes, heterozygous mutations in the ITGB3 gene, homozygous mutations in the methionine synthase reductase (MTR) gene, and heterozygous mutations in the methylenetetrahydrofolate reductase (MTHFR) gene. Anti-phosphatidylserine antibodies were detected. Morphological and histological examination confirmed disturbances in the placental blood circulation system.
Conclusions. Homocysteine metabolism disorders are significant risk factors for both severe PE and vascular complications in pregnant women with DM. Genetic mutations, such as homozygous MTR and heterozygous MTHFR mutations, may contribute to pregnancy complications. Mutations in the SERPINE1, ITGA2, and ITGB3 genes increase the risk of thrombophilia, which, in the context of Hcy metabolism disorders, can worsen pregnancy outcomes. Histological findings confirm that thrombophilia resulting from Hcy metabolism disturbances adversely affects the uteroplacental blood circulation, leading to intrauterine growth restriction.
The study was conducted following the principles of the Declaration of Helsinki. The study protocol was approved by the ethics committee of the participating institution. Informed consent was obtained from all patients for the research.
The authors declare no conflict of interest.
Keywords: preeclampsia, folate cycle, homocysteine, hyperhomocysteinemia, antiphospholipid syndrome.
REFERENCES/ЛІТЕРАТУРА
1. Abrahams VM, Chamley LW, Salmon JE. (2017, Sep). Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation. Arthritis Rheumatol. 69(9): 1710-1721. Epub 2017 Jul 18. https://doi.org/10.1002/art.40136; PMid:28445926 PMCid:PMC5575987
2. Afaq E, Ali A, Jamil R, Waseem HF. (2023). Association of plasma folic acid, vitamin-B12 and homocysteine with recurrent pregnancy loss. A case control study. Pak J Med Sci. 39(5): 1280-1285. https://doi.org/10.12669/pjms.39.5.7432; PMid:37680790 PMCid:PMC10480748
3. Bošković A, Ćuk A, Mandrapa V, Dugandžić Šimić A, Cvetković I, Orlović Vlaho M et al. (2024, Jan 3). Association of MTHFR polymorphism, folic acid and vitamin B12 with serum homocysteine levels in pregnant women. Biomol Biomed. 24(1): 138-143. https://doi.org/10.17305/bb.2023.9260; PMid:37622180 PMCid:PMC10787622
4. Campbell NE, Deer EM, Herrock OT, LaMarca BB. (2022, Aug 12). The Role of Different Lymphoid Cell Populations in Preeclampsia Pathophysiology. Kidney360. 3(10): 1785-1794. https://doi.org/10.34067/KID.0001282022; PMid:36514732 PMCid:PMC9717666
5. Chang KJ, Seow KM, Chen KH. (2023б Feb 8). Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. Int J Environ Res Public Health. 20(4): 2994. https://doi.org/10.3390/ijerph20042994; PMid:36833689 PMCid:PMC9962022
6. Dai C, Fei Y, Li J, Shi Y, Yang X. (2021, May 6). A Novel Review of Homocysteine and Pregnancy Complications. Biomed Res Int. 2021: 6652231. https://doi.org/10.1155/2021/6652231; PMid:34036101 PMCid:PMC8121575
7. Gu C, Wu W, Lai K, Li H, Wu L, Lu W et al. (2023, Apr 27). Maternal pre-pregnancy BMI, MTHFR polymorphisms, and the risk of adverse pregnancy outcomes in pregnant women from South China: a retrospective cohort study. BMC Pregnancy Childbirth. 23(1): 295. https://doi.org/10.1186/s12884-023-05605-6; PMid:37106323 PMCid:PMC10134578
8. Headen K, Jakaite V, Mesaric VA, Scotta C, Lombardi G et al. (2024, Apr 30). The Role of Regulatory T Cells and Their Therapeutic Potential in Hypertensive Disease of Pregnancy: A Literature Review. Int J Mol Sci. 25(9): 4884. https://doi.org/10.3390/ijms25094884; PMid:38732104 PMCid:PMC11084408
9. Holianovskyi O, Morozova O, Frolov S. (2023). Hiperhomotsysteinemiia yak marker akusherskoi patolohii. Reproduktyvne zdorov'ia zhinky. (3): 52-59. URL: https://repro-health.com.ua/article/view/283896.
10. Hu J, Guo Q, Liu C, Yu Q, Ren Y, Wu Y et al. (2024). Immune cell profiling of preeclamptic pregnant and postpartum women by single-cell RNA sequencing. Int Rev Immunol. 43(1): 1-12. Epub 2022 Nov 11. https://doi.org/10.1080/08830185.2022.2144291; PMid:36369864
11. Hu XJ, Su MR, Cao BW, Ou FB, Yin RX, Luo AD. (2023, Oct 1). Relationship between the methylenetetrahydrofolate reductase (MTHFR) rs1801133 SNP and serum homocysteine levels of Zhuang hypertensive patients in the central region of Guangxi. Clin Hypertens. 29(1): 26. https://doi.org/10.1186/s40885-023-00250-9; PMid:37777810 PMCid:PMC10543866
12. Kalafat E, Thilaganathan B. (2017, Dec). Cardiovascular origins of preeclampsia. Curr Opin Obstet Gynecol. 29(6): 383-389. https://doi.org/10.1097/GCO.0000000000000419; PMid:28961633
13. Karumanchy SA. (2016). Angiogenic factors in preeclampsia: from diagnosis to therapy. Hypertension. 67: 1072-1079. https://doi.org/10.1161/HYPERTENSIONAHA.116.06421; PMid:27067718
14. Kaur G, Kohli B, Sood R. Correlation of hyperhomocysteinemia with severity of pregnancy-induced hypertension – a case-control study. Curr Trends Diagn Treat.2019;3:23-26. https://www.ctdt.co.in/doi/pdf/10.5005/jp-journals-10055-0068. https://doi.org/10.5005/jp-journals-10055-0068
15. Korchynska OO, Rostoka LM, Liakh OI ta insh. (2016). Hiperhomotsysteinemiia yak osnova riznykh patolohichnykh staniv. Naukovo-praktychnyi zhurnal dlia pediatriv ta likariv zahalnoi praktyky – simeinoi medytsyny. 3-4(33-34): 26-34.
16. Kornacki J, Olejniczak O, Sibiak R, Gutaj P, Wender-Ożegowska E. (2023, Dec 25). Pathophysiology of Pre-Eclampsia-Two Theories of the Development of the Disease. Int J Mol Sci. 25(1): 307. https://doi.org/10.3390/ijms25010307; PMid:38203478 PMCid:PMC10779413
17. Kornacki J, Wirstlein P, Wender-Ozegowska E. (2020, Oct 14). Markers of Endothelial Injury and Dysfunction in Early- and Late-Onset Preeclampsia. Life (Basel). 10(10): 239. https://doi.org/10.3390/life10100239; PMid:33066445 PMCid:PMC7602169
18. Kubo Y, Shoji K, Tajima A, Horiguchi S, Fukuoka H, Nishikawa M et al. (2023, Jul 1). Serum 5-Methyltetrahydrofolate Status Is Associated with One-Carbon Metabolism-Related Metabolite Concentrations and Enzyme Activity Indicators in Young Women. Int J Mol Sci. 24(13): 10993. https://doi.org/10.3390/ijms241310993; PMid:37446171 PMCid:PMC10341762
19. Long S, Goldblatt J. (2016, Apr). MTHFR genetic testing: Controversy and clinical implications. Aust Fam Physician. 45(4): 237-240.
20. Tsoi SM, Steurer M, Maltepe E, Fineman JR. (2024, Sep). Preeclampsia and the Barker hypothesis: are we beginning to see the trees in the forest? Pediatr Res. 96(4): 826-827. Epub 2024 May 31. https://doi.org/10.1038/s41390-024-03264-7; PMid:38822134 PMCid:PMC11502483
21. Viall CA, Chamley LW. (2015, May). Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature. Autoimmun Rev. 14(5): 446-471. https://doi.org/10.1016/j.autrev.2015.01.008; PMid:25620498
22. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. (1999, Mar). Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol. 180; 3 Pt 1: 660-664. https://doi.org/10.1016/S0002-9378(99)70269-3; PMid:10076144
23. Wang H, Li H, Rong Y, He H, Wang Y, Cui Y et al. (2024, May 24). Bioinformatics identification and validation of maternal blood biomarkers and immune cell infiltration in preeclampsia: An observational study. Medicine (Baltimore).;103(21): e38260. https://doi.org/10.1097/MD.0000000000038260; PMid:38788026 PMCid:PMC11124706
24. Wu H, Zhu P, Geng X, Liu Z, Cui L, Gao Z et al. (2017, May). Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis. Arch Gynecol Obstet. 295(5): 1105-1118. https://doi.org/10.1007/s00404-017-4322-z; PMid:28283826
25. Yefymenko OK. (2015). Vyznachennia rivnia homotsysteinu yak markera ryzyku rozvytku preeklampsii vazhkoho stupenia. Aktualni pytannia pediatrii, akusherstva ta hinekolohii. 1: 120-121. https://doi.org/10.11603/24116-4944.2015.1.4699